BlueChew: What the FDA Letter Means for What You Pay

This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://bluechew.com in August 2025 and has observed that your website offers various compounded drug products, including sildenafil and tadalafil.

1. 1

   “The following claims concerning compounded sildenafil and tadalafil products appear on your website: • "SIL: Same active as Viagra" • "TAD: Same active as Cialis" • "The chewable tablets offered through BlueChew work for most patients. They are compounded medications made with the same active ingredients (Sildenafil, Tadalafil, and Vardenafil) used in Food and Drug Administration (FDA) approved erection-enhancing medications such as Viagra, Cialis…."”

2. 2

   “Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not. As a result, these claims are false or misleading and your products are therefore misbranded under sections 502(a) and 502(bb) of the FDCA.”

1. 1

   Letter issued

   September 2025

2. 2

   15-working-day response window

   FDA gives the company 15 working days to respond in writing.

3. 3

   Close-out, if issued

   FDA may post one once it is satisfied the cited issues have been corrected.

bluechew.com returned a live storefront when we checked in August 2026, still marketing under the BlueChew brand named in the letter.

BlueChew sits outside GLP-1 entirely — a useful reminder this class of letter isn't specific to weight-loss compounders. The objection is the same in kind as the GLP-1 letters above: comparing a compounded drug's active ingredient to an FDA-approved brand (Viagra, Cialis) on a product page overstates FDA's role. It says nothing about whether BlueChew's tablets work or are dosed safely.

As of August 2026, FDA’s public tracking for this letter does not show a logged company response. Companies are not required to make a response public, and FDA does not always update this field promptly — this is not evidence BlueChew failed to respond.